MILLENNIUM BIOTECHNOLOGIES GROUP INC. (OTCBB: MBTG)

Dear Reader,

Recently, Millennium Biotechnologies, Inc. (OTC BB: MBTG) announced that its RESURGEX® products are now tested and certified not to contain banned substances by the Banned Substance Control Group's (BSCG) certification program - the only certification program in the U.S. that uses a World Anti-Doping Agency accredited laboratory to detect for dangerous, banned substances in nutritional supplements.

Today MBTG reported that it had retained a cutting-edge sports marketing and corporate consulting firm to help lead the company's marketing and PR efforts as it launches its new NCAA-compliant 'Fusion' product into the collegiate and professional sports industry. (See News Below)

Please take a moment to read the latest NEWS from MBTG

Breaking *NEWS* from MBTG

Press Release Source: Millennium Biotechnologies
Tuesday December 12, 8:00 am ET

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Millennium Biotechnologies (OTCBB:MBTG - News), manufacturer of Resurgex, a popular line of nutritional supplements in the medical and sports industries, announced today that it has retained the Blake and Bosworth Group, a cutting-edge sports marketing and corporate consulting firm, to help lead the company's marketing and PR efforts as it launches its new NCAA compliant 'Fusion' product into the collegiate and professional sports industry.

The Blake and Bosworth Group, a sports marketing firm that specializes in developing and executing marketing strategies for global consumer brands, will spearhead the Resurgex launch into professional and collegiate sports and the neutraceutical mass market. Blake and Bosworth is led by Dennis Blake and Jamie Bosworth, formerly of the Callaway Golf Company. During their tenure in the golf industry Dennis and Jamie were instrumental in developing and executing several successful product launches at the Odyssey, Ben Hogan and Top-Flite brands. They also pioneered the first-ever cross promotional marketing campaign between NASCAR and the golf industry. "We are excited about the opportunity to assist Millennium Biotechnologies in its effort to expand the brand's reach," said Jamie Bosworth. "Resurgex is a truly unique product that finally answers the call from professional and collegiate athletes for a supplement that is compliant and effective," said James Bosworth.

Designed for the medical community to address fatigue, muscle loss and oxidative stress commonly found in those with immunocompromised conditions, the Resurgex line is now expanding into the collegiate and professional sports sectors. Unlike most other products on the market which load up on excessive amounts of protein and high amounts of sugar and stimulants, Resurgex Fusion is unique in that it delivers a balanced combination of whole food calories and therapeutic levels of important supportive nutrients that aid recovery and improve performance in athletes undergoing rigorous training.

Resurgex Fusion has outperformed the leading nutritional formulas in double blind, placebo controlled trials conducted in both strength and endurance athletes. In addition, each batch of Resurgex Fusion is tested and certified not to contain banned substances by the Banned Substance Control Group's (BSCG) certification program, the only certification program in the U.S. that uses a World Anti Doping Agency (WADA) accredited laboratory to detect for dangerous banned substances in nutritional supplements (please see http://www.stockupticks.com/profiles/12-7-06.html).

The Resurgex line of products finally represents a well thought out, medically accepted and scientifically substantiated formula that address the very nutritional needs of athletes similar to those shared by the chronically ill patient. Several elite athletes have started to take notice, as the products are now being used by numerous professional sporting organizations.

"We could not be happier to have the Blake and Bosworth Group join our team in introducing this advanced product to athletes around the world," said Jerry Swon, President of Millennium Biotechnologies. "Dennis Blake and James Bosworth's experience with launching consumer products in the sports industry is unrivaled. We are excited to team up with them to become the leading innovators in nutritional supplements."

About Millennium Biotechnologies, Inc.

Millennium Biotechnologies, Inc. is a research-based pharmaceutical company and a pioneer in the emerging field of specialized nutritional supplements. The company's flagship products, RESURGEX(r), RESURGEX Plus(r), and RESURGEX Select(r), are designed to assist in reducing fatigue and oxidative stress, maintaining lean muscle and immune support in immunocompromised conditions. In addition, Resurgex products were developed to address the multiple nutritional needs of professional athletes as well as those who are involved in regular exercise programs. Millennium Biotechnologies, Inc. is a wholly owned subsidiary of Millennium Biotechnologies Group, Inc., a publicly-traded company (OTC BB:MBTG.OB - News). For more information about Millennium Biotechnologies, please call Frank Guarino, Chief Financial Officer, at FGuarino@Milbiotech.com or call (908) 604-2500. For more information about the Resurgex line of products visit http://www.resurgex.com.

About The Blake and Bosworth Group

The Blake and Bosworth Group, headquartered in Bernardsville, New Jersey, is a full-service Sports Marketing and Corporate Consulting firm owned and managed by Dennis Blake and James Bosworth, formerly of the Callaway, Top-Flite and Ben Hogan golf companies. The Sports Marketing Group specializes in designing and implementing marketing strategies aimed at maximizing brand awareness by initiating sponsorship and promotional opportunities with various sporting entities including the PGA Tour, the NHL, and NASCAR. The Blake and Bosworth Group place particular emphasis on measuring a client's return on investing in sports marketing by utilizing a proprietary marketing database that benchmarks the results of a client's marketing spend against various models derived from actual marketing investments of Fortune 1000 companies. The Corporate Consulting Group works with sports-centric consumer brands, providing services targeted at improving efficiencies in all areas of business operations including sales, marketing, public relations, product development, manufacturing, R&D and distribution.

Millennium plans to file with the Securities and Exchange Commission and mail to its stockholders a proxy statement which will contain information about Millennium, the sale of its assets and the formation and capitalization of RAC Nutrition (the ``Proposed Transaction'') and related matters. Stockholders are urged to read the proxy statement carefully when it is available, as it will contain important information that stockholders should consider before making a decision about the Proposed Transaction. In addition to receiving the proxy statement from Millennium by mail, stockholders also will be able to obtain the proxy statement, as well as other filings containing information about Millennium, without charge, from the Securities and Exchange Commission's website (http://www.sec.gov). This announcement is neither a solicitation of proxy, an offer to purchase, nor a solicitation of an offer to sell shares of Millennium. Millennium and its executive officers and directors may be deemed to be participants in the solicitation of proxies from Millennium's stockholders with respect to the Proposed Transaction. Information regarding any interests that Millennium's executive officers and directors may have in the Proposed Transaction will be set forth in the proxy statement.

This release includes certain forward-looking information that is based upon management's beliefs as well as on assumptions made by and data currently available to management. This information which has been, or in the future may be, included in reliance on the ``safe harbor'' provisions of the Private Securities Litigation Reform Act of 1995, is subject to a number of risks and uncertainties, including but not limited to uncertainty as to market acceptance of our products and the factors identified in the Company's 10-KSB and other documents filed with the Securities and Exchange Commission. Actual results may differ materially from those anticipated in such forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein may not be realized. The Company undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.

Contact:

Millennium Biotechnologies
Frank Guarino, 908-604-2500
FGuarino@Milbiotech.com
or
The Blake and Bosworth Group
Dennis Blake, 908-953-8400
dblake@blakeandbosworth.com

Source: Millennium Biotechnologies
>

About Millennium Biotechnologies

Millennium Biotechnologies, Inc., ("Millennium""MBTG") is a wholly owned subsidiary of Millennium Biotechnologies Group, Inc.  MBTG is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements. MBTG's flagship products include: RESURGEX®, RESURGEX Plus™, and RESURGEX Select™.

The Resurgex® family of products was designed to provide sophisticated nutritional support for immuno-compromised individuals as well as elite-level athletes.

In stark contrast to the nutritional products available in the medical market today, the Resurgex formulas combine healthy, whole food calories along with a proprietary blend of supportive micro-nutrients. Addressing the nutritional needs of individuals undergoing medical treatment for such conditions as HIV/AIDS, hepatitis and cancer, Millennium’s line of nutraceuticals support healthy weight, lean muscle, reduced oxidative stress and increased energy production. RESURGEX®, RESURGEX Plus™, and RESURGEX Select™ are proudly recommended and prescribed at a great number of high profile medical institutions nationwide. 

Born from its success in the medical market, Resurgex nutritionals also play important supportive roles in the recovery of professional and amateur level athletes. Resurgex products for athletes combine unparalleled clinical support for its capacity to aid the athlete’s ability to recover quicker so as to perform at a higher level. The variation in caloric levels, all while providing the same advanced micro-nutrient profile, makes the Resurgex line ideal for the endurance as well as strength athlete.

Convenient dosing formats, premier flavor systems, third party insurance coverage and multiple distribution outlets helps to increase adherence and availability of the Resurgex line amongst its users. Millennium plans to continue building its product line in its quest to provide optimal and proprietary nutritional support for the medical as well as the athletic communities.

Millennium is currently in the process of redesigning and restructuring the company to better suit its two primary core competencies of identified care for athletes and cancer patients. Millennium plans to file with the Securities and Exchange Commission and mail to its stockholders a proxy statement which will contain information about Millennium, the sale of its assets and the formation and capitalization of RAC Nutrition (the "Proposed Transaction") and related matters.

Resurgex® Provides Strength And Body Composition Benefits To Athletes: The Rutgers Studies

Millennium Biotechnologies, Inc. recently announced preliminary results of its second double blind, placebo controlled clinical trial that found its Resurgex® nutritional formula provided improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat in Rutgers University Division 1 football players (strength athletes). The preliminary results showed Resurgex® out performed a leading sports nutritional formula commonly used by athletes. This emerging new data, coupled with the first trial that found its Resurgex® nutritional formula provided enhanced performance parameters and reduced oxidative stress levels (free radical damage caused by exercise) in Rutgers University Division 1 soccer players (endurance athletes), further suggests an important role for Resurgex in the sports fitness field.  - BioSpace.com 8/22/06

Improved Performance: There were significant changes in performance capacity and reduced oxidative stress in the Resurgex group as compared to the Control group (Boost)

Improved Lactic Acid Response: The Resurgex group had improved lactic acid responses to exercise and time to exhaustion as compared to the controls 

Reduced Oxidative Stress: The Resurgex group had a significantly lower oxidative stress markers isoprostanes and (LPO’s) compared to control 

Improved Body Composition:  while both groups gained weight, the Resurgex (experimental) group gained muscle and lost a slight amount of body fat while the Gatorade Performance Shake (control) group gained ½ of their weight as body fat 

Improved Power/Strength: using Wingate Testing, Peak power was measured for each test and standardized by body weight. The increase in peak power in the Resurgex group was approximately 86% greater than the increase in the Gatorade Performance Shake group.

Improved Recovery Parameters: the Resurgex group had a significant improvement in their testosterone:cortisol ratio while the Gatorade Performance Shake group had a decrease in this ratio.

*Going Beyond Sugar & Stimulants*

International Olympic Committee (IOC)
Compliant
National Collegiate Athletic Association (NCAA)
Compliant

MBTG Products

Resurgex Select offers nutrition specially designed for patients undergoing active treatment. During treatment for cancer, proper nutrition can help you feel stronger and more energetic. Resurgex Select is designed to help you get the calories and nutrients you need.
A good source of energy during treatment

Resurgex Select offers a healthy combination of high quality protein, complex carbohydrates, MCTs, and omega 3 DHA to give your body the fuel it needs to stay strong. In addition, a multipart fruit and vegetable extract and FOS help maintain GI health. 

Resurgex Plus

A Good Source of Energy
The nutrients, whey protein, complex carbohydrates, and essential fats in Resurgex Plus can help you generate energy naturally and assist in healthy cell development.

A Unique Formulation of Antioxidants
In addition to being rich in vitamins C and E, zinc, and selenium, Resurgex Plus contains GliSODin® (vegetarian superoxide dismutase).

Recent News From Millennium

Press Release Source: Millennium Biotechnologies Group
Wednesday December 6, 9:00 am ET

IRVINE, Calif., Dec. 6, 2006 (PRIME NEWSWIRE) -- Millennium Biotechnologies (OTC BB:MBTG.OB - News) is proud to announce that it is an active participant in the Banned Substance Control Group's (BSCG) certification program. This is the only certification program in the U.S. that uses a World Anti Doping Agency accredited laboratory to detect for dangerous banned substances in nutritional supplements. Each batch of Millennium's line of Resurgex products are now tested and certified not to contain substances such as hormones, steroids, stimulants, diuretics, etc. that are banned for professional and collegiate sports. "By participating in this program, we provide our Resurgex consumers greater confidence that we are taking all precautions to ensure that harmful anabolic agents and stimulants are not in our products," states Carl Germano, RD, CNS, CDN Vice President of Research & Product Development for Millennium Biotechnologies. "The consumer and athlete can now be assured that our Resurgex line of products can be safely consumed as each batch is tested for a list of substances that are banned by organizations such as the International Olympic Committee (IOC), the World Anti-Doping Agency (WADA), the United States Anti-Doping Agency (USADA), the National Collegiate Athletic Association (NCAA), the National Football League (NFL), and many other professional and amateur sports leagues."

With over 5 years in the medical market as a nutritional adjunct to medical care for immunocompromised conditions and several successful studies including 2 double blind, placebo controlled trials in Division 1 athletes, the Resurgex line of products are breaking new ground for credibility and professionalism in the sports nutrition sector. The final set of results from Millennium's sponsored Division 1 Football trial at Rutgers University have shown that Resurgex had a significant effect on recovery markers including testosterone:cortisol ratios compared to a popular sports beverage on the market. "Along with our previous statistically significant improvements in body composition and strength parameters, the recovery marker data continues to validate Resurgex as an important nutritional adjunct for the athlete," states Mr. Germano. "As we have seen in the medical market, Resurgex is now able to offer the athlete a product that will assist in recovery in efforts to improve performance. In addition, our participation in the BSCG program continues to set us apart from the competition."

To read the complete release and disclaimer, Click Here

Press Release Source: Millennium Biotechnologies Group
Tuesday November 7, 12:42 pm ET

BASKING RIDGE, N.J., Nov. 7, 2006 (PRIMEZONE) -- Millennium Biotechnologies (OTC BB:MBTG.OB - News), manufacturer of Resurgex, a popular line of nutritional supplements, announced the appointment of Don Sperling, former Senior Vice President of NBA Entertainment to the Company's sports marketing team.

The Resurgex line had primarily been used to relieve fatigue commonly found in those with deficiencies of the immune system. In 2005, Millennium Biotechnologies began supplying professional sporting organizations with Resurgex to increase recovery and to improve performance in athletes undergoing rigorous training. The appointment of Mr. Sperling is indication of the company's continuing focus on becoming one of the leading suppliers of specialized nutritional supplements to professional and collegiate athletes.

Mr. Sperling brings to Millennium Biotechnologies over 20 years of sports marketing and television media production experience. During Mr. Sperling's fifteen year tenure as Senior Vice President and Executive Producer of NBA Entertainment, NBA TV and NBA.com, the NBA became the largest producer and broadcaster of sports programming and digital media with over 240 affiliates worldwide.

"Don's background is perfectly suited to design targeted marketing strategies appropriate for the launch of our line of sports products," said Jerry Swon, President and CEO of Millennium Biotechnologies. "Don is the perfect leader to help us build off of our current success."

Not only was Don the creator of "NBA Inside Stuff," ABC's longest running weekly sports and entertainment show, but in 1997 he was one of the leading forces behind the launch of the Women's National Basketball Association (WNBA), earning Don and his team the coveted "Sports Marketer of the Year" award.

"This cutting edge product is in the right place at the right time," said Don Sperling. ``Resurgex has clinically proven benefits that will help all athletes perform at peak levels longer and decrease recovery time from modern day training regimens."

To read the complete release and disclaimer, Click Here

BASKING RIDGE, N.J., Oct. 25, 2006 (PRIMEZONE) -- Millennium Biotechnologies Group, Inc. (OTC BB:MBTG.OB - News) announced today that it has entered into an Asset Purchase Agreement with RAC Nutrition Corporation, a newly formed company controlled by Aisling Capital II, LP in accordance with the previously announced letter of intent. Pursuant to the Asset Purchase Agreement, Millennium will exchange all of the assets used in Millennium's nutraceutical business to RAC Nutrition for shares of common stock of RAC Nutrition. The newly formed RAC Nutrition will be initially capitalized by the issuance to Aisling and other investors of $15 million in convertible preferred stock. The Asset Purchase Agreement, which has been filed as an exhibit to Millennium's Current Report on Form 8-K, is subject to various conditions, including approval by Millennium's stockholders. Aisling Capital II, LP is a leading private equity fund that invests in life science companies developing biopharmaceutical products and creating businesses based on advanced life sciences technology.

To read the complete release and disclaimer, Click Here

Press Release Source: Millennium Biotechnologies, Inc.
Thursday August 31, 9:15 am ET

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Aug. 31, 2006--Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTCBB:MBTG - News), a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements for the medical market, today announced initial distribution and sales of its Resurgex® products in the professional and collegiate sport marketplaces. With Resurgex® outperforming leading nutritional formulas in 2 double blind, placebo controlled trials conducted in both strength and endurance athletes, the important role for Resurgex® in the sports medicine and fitness field is being unanimously accepted. In strength athletes, the benefits associated with Resurgex® demonstrated improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat as compared to a leading sports nutritional formula. In endurance athletes, Resurgex® was shown to provide enhanced performance parameters and reduced oxidative stress levels (free radical damage caused by exercise).

"We are very excited about the opportunities for Resurgex in professional sports. Unfortunately, the sports marketplace has been dominated by products that contain artificial stimulants, steroid precursors or excessive amounts of protein. In addition, the marketplace is rampant with products with unsubstantiated claims. Resurgex products finally represent well thought out, medically accepted and scientifically substantiated formulas that address the very nutritional needs of athletes similar to those shared by the chronically ill patient." said Carl Germano, RD, CNS, CDN, Senior Vice President of Product Development and Research for Millennium Biotechnologies. "With more then 5 years acceptance and success in the medical marketplace and scientific substantiation demonstrating performance and strength benefits in athletes, Resurgex® represents one of the most credible nutritional formulas to come to the sports market in decades." 

To read the complete release and disclaimer, Click Here

Source: Millennium Biotechnologies Group, Inc.
Aug 22, 2006

BASKING RIDGE, N.J., Aug 22, 2006 (BUSINESS WIRE) -- Millennium Biotechnologies, Inc. (OTCBB:MBTG), a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements for the medical market, today announced preliminary results of its second double blind, placebo controlled clinical trial that found its Resurgex(R) nutritional formula provided improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat in Rutgers University Division 1 football players (strength athletes). The preliminary results showed Resurgex(R) out performed a leading sports nutritional formula commonly used by athletes. This emerging new data, coupled with the first trial that found its Resurgex(R) nutritional formula provided enhanced performance parameters and reduced oxidative stress levels (free radical damage caused by exercise) in Rutgers University Division 1 soccer players (endurance athletes), further suggests an important role for Resurgex in the sports fitness field.

"While this human trial further validates the efficacy of Resurgex(R) during strenuous activity, we are very excited about these initial results which reinforce the functionality of our product now in the strength athlete," said Carl Germano, RD, CNS, CDN, senior vice president of product development and research for Millennium Biotechnologies. "These preliminary findings provide further confirmation of the importance of Resurgex to address the true nutritional needs of the athlete. We have focused on assisting the athlete's recovery that enables for better performance. While our first trial demonstrated the ability for Resurgex to improve performance while lowering oxidative stress, this study is pointing to the ability of Resurgex to improve strength parameters, increasing muscle gain while reducing body fat." 

To read the complete release and disclaimer, Click Here
a

**Please Note**

Financial Highlights For MBTG

Total revenues  generated from the sales of  RESURGEX(r),  RESURGEX  PLUS(tm) and RESURGEX  SELELCT(tm)  for the quarter ended June 30,  2006 were $200,898  an increase of  approximately  26% from the second quarter in 2005, which had total revenues of $159,169. 

Recent Trade: 0.22 (12-12-06) 52wk Range: 0.16 - 0.52 Avg Vol (3m): 89,335 Market Cap: 15.1M Sector: Healthcare Industry: Biotechnology State of Incorporation: Delaware Fiscal Year Ends: 31-Dec Revenue (ttm): 766.79K Shares Outstanding: 67.96M Float: 55.03M Transfer Agent: American Stock Transfer  CIK: 0000072170 Shareholders of Record:  534 as of 2006-04-17

TO CONTACT MILLENNIUM

---

*** The Bull is Running. ***
There may never be a better time to feature YOUR company
to over 1 MILLION investors.

To learn more about our programs email us directly at info@stockupticks.com

Disclaimer: StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated (MP).  The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. Past performance is no guarantee of future results. This report is a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision.  MP has been paid twenty four thousand dollars by Millennium Biotechnologies, Inc. for preparation and distribution of this report and other advertising services over a ninety day period. This constitutes a conflict of interest as to MP’s ability to remain objective in its communication regarding the subject company.  Write or call MP for detailed disclosure as required by Rule 17b of the Securities Act of 1933/1934 - Market Pathways 17595 Harvard Ave., Suite C519 Irvine, CA  92614.  MP is not an investment advisor and this report is not investment advice. This information is neither a solicitation to buy nor an offer to sell securities but is a paid advertisement.  Information contained herein contains forward-looking statements and is subject to significant risks and uncertainties, which will affect the results.  The opinions contained herein reflect our current judgment and are subject to change without notice. MP and/or its affiliates, associates and employees from time to time may have either a long or short position in securities mentioned.  Information contained herein may not be reproduced in whole or in part without the express written consent of Market Pathways Financial Relations Incorporated.